Kutiyal Aditya Singh, Gupta Naresh, Garg Sandeep, Hira Harmanjit Singh
Senior Resident, Department of Internal Medicine, Maulana Azad Medical College , New Delhi, India .
Director- Professor, Department of Internal Medicine, Maulana Azad Medical College , New Delhi, India .
J Clin Diagn Res. 2017 Feb;11(2):OC09-OC13. doi: 10.7860/JCDR/2017/24022.9249. Epub 2017 Feb 1.
Tuberculosis is one of the leading infectious diseases with high morbidity and mortality in the developing countries. Tuberculosis is also rarely associated with hypercoagulable state and very limited literature is available on this association.
To study the haematological and haemostasis laboratory parameters, to correlate the abnormalities for a hypercoagulable state and to study the outcome with anti-tubercular therapy.
The study population included 128 patients with newly diagnosed tuberculosis. Anti-tubercular therapy naïve patients were studied for haemostasis parameters like Prothrombin time, Activated Partial Thromboplastin time, Factor VIII, Fibrinogen and D-dimer and haematological parameters like Haemoglobin, White Blood Cells, Platelet count, Erythrocyte Sedimentation Rate (ESR), Lactate Dehydrogenase, C-reactive protein and albumin. At the end of the second month of anti-tubercular therapy, results were compared and analysed using statistical package for the social sciences software (SPSS).
Prothrombin levels were deranged in 50%. Activated Partial Thromboplastin time levels were deranged in 18%. Deranged Factor VIII levels were found in 35.15%. Fibrinogen levels were deranged in 57%. D-Dimer positivity was found in 57.8% patients. Anaemia was found in 75.78%, Leukocytosis in 49.21%, Thrombocytopenia in 37.5% and Hypoalbuminaemia in 75%. ESR levels were raised in 98.43%. Follow up comparison analysis revealed significant p-value for all the parameters except Factor VIII and Activated Partial Thromboplastin time. Similar trend was also observed within different groups of Tuberculosis patients.
Tuberculosis does favour a hypercoagulable state with increased risk of developing thrombosis and significant improvement with the anti-tubercular treatment alone.
结核病是发展中国家发病率和死亡率较高的主要传染病之一。结核病也很少与高凝状态相关,关于这种关联的文献非常有限。
研究血液学和止血实验室参数,关联高凝状态的异常情况,并研究抗结核治疗的结果。
研究人群包括128例新诊断的结核病患者。对未接受过抗结核治疗的患者进行止血参数(如凝血酶原时间、活化部分凝血活酶时间、因子VIII、纤维蛋白原和D-二聚体)以及血液学参数(如血红蛋白、白细胞、血小板计数、红细胞沉降率(ESR)、乳酸脱氢酶、C反应蛋白和白蛋白)的研究。在抗结核治疗的第二个月末,使用社会科学统计软件包(SPSS)对结果进行比较和分析。
50%的患者凝血酶原水平紊乱。18%的患者活化部分凝血活酶时间水平紊乱。35.15%的患者因子VIII水平紊乱。57%的患者纤维蛋白原水平紊乱。57.8%的患者D-二聚体呈阳性。75.78%的患者存在贫血,49.21%的患者存在白细胞增多,37.5%的患者存在血小板减少,75%的患者存在低白蛋白血症。98.43%的患者ESR水平升高。随访比较分析显示,除因子VIII和活化部分凝血活酶时间外,所有参数的p值均具有显著性。在不同组的结核病患者中也观察到了类似趋势。
结核病确实有利于形成高凝状态,增加发生血栓形成的风险,且仅抗结核治疗就能显著改善病情。